Skip to main content

Table 3 Periprocedural outcome

From: Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation

Variables

MR-group (n = 34)

Control-group (n = 43)

p value

Full-sternotomy, n (%)

26 (76.5)

35 (81.4)

0.597

Medtronic HVAD device, n (%)

33 (97.1)

40 (93.0)

0.428

Implantation of tRVAD, n (%)

12 (35.3)

9 (20.9)

0.160

Additional AVR, n (%)

5 (14.7)

6 (14.0)

0.925

Additional TV repair, n (%)

4 (11.8)

1 (2.3)

0.095

Duration of surgery (min), mean ± SD

300.5 ± 100.2

332.9 ± 93.7

0.155

Cardiopulmonary bypass time (min), mean ± SD

155.6 ± 68.7

154.2 ± 61.5

0.930

  1. tRVAD temporary right ventricular assist device, AVR aortic valve replacement, TV repair tricuspid valve repair